DISCLAIMER: GOLDINVESTMENTCOMPANIES.COM IS AN AFFILIATED PARTNER FOR GOLDCO PRECIOUS METALS, AUGUSTA PRECIOUS METALS, AND BIRCH GOLD GROUP, PROMOTING THEIR GOLD IRA, GOLD 401K TRANSFER AND BITCOIN IRA SERVICES AND PRODUCTS.
Sirona Biochem’s (TSXV:SBM) chief scientific officer Géraldine Deliencourt-Godefroy provides an update on the progress of its breakthrough anti-aging compound, as the company gears up for market launch in 2025.
00:00 Intro
00:40 Overview of Sirona Biochem’s breakthrough anti-aging compound TFC-1326
02:43 Strategy for commercialization
04:33 Trademark name for the TFC-1326 and steps taken to launch a new product
06:57 Plans for more clinical trials
07:51 Timeline for product launch
08:50 Plans for 2024
#biotechstocks #biotech #investing
________________________________________________________________
Investing News Network (INN)
Find out more about Sirona Biochem: https://bit.ly/3T0Eddu
Browse our 2023 outlook reports:
http://bit.ly/3JHyR1M
Follow us Facebook:
https://www.facebook.com/investing.news.your.trusted.source
Follow us on Twitter:
@INN_Resource
________________________________________________________________
The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.
